Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 80,000
Avg Vol 40,326
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 37%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets in Canada and internationally. It provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific pharmaceutical products...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Address:
480 University Avenue, Suite 1502, Toronto, Canada
Latest News on AVCNF
No data available.